カテゴリー： Grand View Research, 世界, 医療/バイオ

世界の人工多能性幹細胞（iPS細胞）生産市場2023-2030：プロセス別、ワークフロー別（リプログラミング、細胞培養）、製品別、用途別（再生医療）、最終用途別、地域別

◆英語タイトル：Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030
	◆商品コード：GRV23NVB025 ◆発行会社（リサーチ会社）：Grand View Research ◆発行日：2023年10月9日 ◆ページ数：200 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：バイオテクノロジー

◆販売価格オプション（消費税別）

Single User	USD5,950 ⇒換算￥904,400	見積依頼/購入/質問フォーム
Multi User/Five User	USD6,950 ⇒換算￥1,056,400	見積依頼/購入/質問フォーム
Global/corporate License	USD8,950 ⇒換算￥1,360,400	見積依頼/購入/質問フォーム

★Grand View Researchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

人工多能性幹細胞（iPS細胞）生産市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の人工多能性幹細胞（iPS細胞）生産市場規模は2030年までに27億6000万米ドルに達すると推定されています。同市場は2023年から2030年にかけて年平均成長率9.3%で拡大する見込みです。胚性幹細胞（ESC）と比較して人工多能性幹細胞（iPSC）の需要が増加していることが市場を大きく牽引しています。幹細胞に関連する倫理的問題がないこと、個別化治療が可能であること、細胞を用いた研究において柔軟性があることなどの利点が、市場成長にとって有利なシナリオを生み出しています。さらに、慢性疾患の流行も人工多能性幹細胞（iPS細胞）生産市場の成長を後押ししています。例えば、国際糖尿病連合（IDF）によると、2021年にはすでに5億3700万人が糖尿病を患っています。

COVID-19パンデミック時の研究活動の高まりは、市場にプラスの影響を与えています。パンデミックは、SARS CoV-2感染によって患者に多くの疾患が発生したため、多くの分野で研究を促進しました。例えば、2021年4月、米国の研究者たちは、COVID-19患者の最大25%が心機能障害に罹患したと発表しました。研究論文を通じて、彼らはiPS細胞由来の心臓細胞をSARS CoV-2に暴露することで発症することを証明し、患者のヒト剖検標本からも同様の変化が確認されました。このような洞察により、人工多能性幹細胞（iPSC）を薬剤や治療法の開発プラットフォームとして利用し、COVID-19の長期的影響の管理に活用することが可能になります。

人工多能性幹細胞は、成人の体細胞から誘導され、さらにESCのような多能性を獲得するように再プログラムされた細胞です。このiPS細胞は、ESCを使用する研究にとって、倫理的に問題のない選択肢であることが証明されつつあります。ESCの樹立は胚盤胞の段階で胚を破壊することにつながるため、倫理的な議論が最も多いです。しかし、人工多能性幹細胞は、体細胞の遺伝的初期化のみを行うことで、研究におけるヒト胚の破壊に関する倫理的問題を解決しました。このことが市場の成長を促進し、創薬、疾患モデリング、毒性試験など数多くの応用をもたらしました。例えば、2021年8月、フェイト・セラピューティクス社は、臨床試験中のFT819による最初の患者の治療を発表しました。FT819はiPS細胞由来の人工CAR-T細胞療法です。また、分化能、自己再生可能性、免疫調節特性など、人工多能性幹細胞のユニークな特性により、再生医療への応用を模索する研究コミュニティーの注目度が高まっていることも、市場拡大の原動力となっています。

人工多能性幹細胞（iPS細胞）生産市場レポートハイライト

- プロセス別では、手作業によるiPSC作製プロセスが市場を支配し、2022年には77.2%の最大収益シェアを占めました。

- ワークフロー別では、細胞培養部門が市場を席巻し、2022年の最大収益シェアは37.3%。細胞培養ワークフローには、iPSC採取製品、拡大製品、分化製品から得られる収益が含まれるため、このセグメントの市場関連性に寄与しています。

- 製品別では、消耗品とキットのセグメントが市場を支配し、2022年には40.3%の最大収益シェアを占めました。iPS細胞分野における絶え間ない研究開発活動が、各種消耗品・キットの需要を牽引しています。

- 用途別では、医薬品開発・探索分野が2022年に43.3%の最大収益シェアで市場を独占しました。

- エンドユーザー別では、バイオテクノロジー・製薬企業セグメントが2022年に59.3%の最大収益シェアで市場を独占しました。iPSCs製品とともに、さまざまなキット、消耗品、器具が入手可能であり、採用されていることが、このセグメントの収益創出を促進しています。

- 北米が市場を支配し、2022年には40.8%の最大収益シェアを占めました。同地域における慢性疾患の罹患率の増加、発達した医療インフラ、民間および政府のイニシアティブによる資金、戦略的ビジネスモデルが、同市場における収益創出の原動力となっています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 人工多能性幹細胞（iPS細胞）生産の市場変数・傾向・範囲
第4章. 人工多能性幹細胞（iPS細胞）生産の世界市場：プロセス別予測・傾向分析
第5章. 人工多能性幹細胞（iPS細胞）生産の世界市場：ワークフロー別予測・傾向分析
第6章. 人工多能性幹細胞（iPS細胞）生産の世界市場：製品別予測・傾向分析
第7章. 人工多能性幹細胞（iPS細胞）生産の世界市場：用途別予測・傾向分析
第8章. 人工多能性幹細胞（iPS細胞）生産の世界市場：最終用途別予測・傾向分析
第9章. 人工多能性幹細胞（iPS細胞）生産の世界市場：地域別予測・傾向分析
第10章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Process
1.1.2. Workflow
1.1.3. Product
1.1.4. Application
1.1.5. End use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Process outlook
2.2.2. Workflow outlook
2.2.3. Product outlook
2.2.4. Application outlook
2.2.5. End use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Induced Pluripotent Stem Cells Production Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Induced Pluripotent Stem Cells Production Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Induced Pluripotent Stem Cells Production: Process Estimates & Trend Analysis
4.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
4.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Manual iPSC Production Process
4.3.1. Manual iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Automated iPSC Production Process
4.4.1. Automated iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Induced Pluripotent Stem Cells Production: Workflow Estimates & Trend Analysis
5.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
5.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Reprogramming
5.3.1. Reprogramming market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cell Culture
5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cell Characterization / Analysis
5.5.1. Cell characterization / analysis market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Engineering
5.6.1. Engineering market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Induced Pluripotent Stem Cells Production: Product Estimates & Trend Analysis
6.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
6.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Instruments/ Devices
6.3.1. Instruments/ devices market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Automated Platforms
6.4.1. Automated platforms market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Consumables & Kits
6.5.1. Consumables & kits market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Media
6.5.2.1. Media market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Kits
6.5.3.1. Kits market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Services
6.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Induced Pluripotent Stem Cells Production: Application Estimates & Trend Analysis
7.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
7.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Drug Development & Discovery
7.3.1. Drug development & discovery market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Regenerative Medicine
7.4.1. Regenerative medicine market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Toxicology Studies
7.5.1. Toxicology studies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Induced Pluripotent Stem Cells Production: End Use Estimates & Trend Analysis
8.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
8.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Research & Academic Institutes
8.3.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Biotechnology & Pharmaceutical Companies
8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Induced Pluripotent Stem Cells Production: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. Induced Pluripotent Stem Cells Production Market by Region: Key Marketplace Takeaway
9.3. North America
9.3.1. North America market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. U.S. market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Canada market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4. Europe
9.4.1. Europe market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.2. UK
9.4.2.1. UK market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Germany market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.4. France
9.4.4.1. France market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Italy market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Spain market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.7. Sweden
9.4.7.1. Sweden market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.8. Norway
9.4.8.1. Norway market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.4.9. Denmark
9.4.9.1. Denmark market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.2. Japan
9.5.2.1. Japan market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.3. China
9.5.3.1. China market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.4. India
9.5.4.1. India market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.5. Australia
9.5.5.1. Australia market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.6. Thailand
9.5.6.1. Thailand market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.5.7. South Korea
9.5.7.1. South Korea market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.6. Latin America
9.6.1. Latin America market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.6.2. Brazil
9.6.2.1. Brazil market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.6.3. Mexico
9.6.3.1. Mexico market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.6.4. Argentina
9.6.4.1. Argentina market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.7. MEA
9.7.1. MEA market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.7.3. South Africa
9.7.3.1. South Africa market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.7.4. UAE
9.7.4.1. UAE market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
9.7.5. Kuwait
9.7.5.1. Kuwait market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
10.2.1. Lonza
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. Axol Biosciences Ltd.
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. Evotec Se
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. Hitachi Ltd.
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. Reprocells Inc.
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. Fate Therapeutics
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Thermo Fisher Scientific, Inc.
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Merck Kgaa
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. StemCellsFactory III
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Applied StemCells, Inc.
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 3 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 4 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 5 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 6 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 7 North America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 8 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 9 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 10 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 14 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 15 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 16 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 17 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 19 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 20 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 21 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 22 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 23 Europe induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 24 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 25 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 26 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 27 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 28 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 29 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 30 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 31 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 32 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 33 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 34 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 35 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 36 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 37 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 38 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 39 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 40 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 41 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 42 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 43 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 44 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 45 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 46 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 47 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 48 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 49 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 50 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 51 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 52 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 53 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 54 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 55 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 56 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 57 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 58 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 59 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 60 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 62 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 63 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 64 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 65 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 66 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 67 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 70 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 71 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 72 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 73 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 74 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 75 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 76 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 77 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 78 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 79 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 80 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 81 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 82 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 83 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 84 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 85 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 86 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 87 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 88 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 89 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 90 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 91 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 92 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 93 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 94 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 95 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 96 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 97 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 98 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 99 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 100 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 101 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 102 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 103 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 104 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 105 Latin America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 106 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 107 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 108 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 109 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 110 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 111 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 112 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 113 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 114 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 115 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 116 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 117 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 118 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 119 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 120 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 121 Middle East and Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 122 Middle East and Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 123 Middle East and Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 124 Middle East and Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 125 Middle East and Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 126 Middle East and Africa induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 127 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 128 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 129 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 130 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 131 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 137 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 138 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 139 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 140 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 141 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 142 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 143 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 144 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 145 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 146 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の人工多能性幹細胞（iPS細胞）生産市場2023-2030：プロセス別、ワークフロー別（リプログラミング、細胞培養）、製品別、用途別（再生医療）、最終用途別、地域別(Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の人工多能性幹細胞（iPS細胞）生産市場2023-2030：プロセス別、ワークフロー別（リプログラミング、細胞培養）、製品別、用途別（再生医療）、最終用途別、地域別

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp